News1 min ago
HuidaGene Therapeutics’ Novel DNA Gene-Editing System Cas12i Patent Granted by USPTO
SHANGHAI and CLINTON, N.J., May 16, 2023 /PRNewswire/ — HuidaGene Therapeutics (辉大基因; HuidaGene), a clinical-stage company focusing on developing gene editing tools and gene therapies, today announced...
